NYSE:CHEHealthcare
Is It Time To Reassess Chemed (CHE) After A 36% One Year Share Price Slide
Investors may be wondering whether Chemed at around US$380.60 is starting to look attractively priced, or if the risk still outweighs the potential reward.
The stock has moved 3.3% over the last week, after a 7.7% decline over 30 days and a 10.2% decline year to date, with a 36.0% decline over the past year and 29.9% and 16.8% declines over three and five years respectively.
These price moves sit against a backdrop of ongoing coverage of Chemed as a healthcare name on the NYSE, with...